Last reviewed · How we verify
Silicone gel Kelo-cort™; — Competitive Intelligence Brief
phase 3
Topical corticosteroid with silicone gel base
Dermatology
Small molecule
Live · refreshed every 30 min
Target snapshot
Silicone gel Kelo-cort™; (Silicone gel Kelo-cort™;) — CHA University. Silicone gel with integrated corticosteroid (likely hydrocortisone or similar) that provides topical anti-inflammatory and scar-reducing effects through moisture retention and steroid delivery to affected skin.
Comparator set
| Drug | Generic | Sponsor | Phase | Class | Target | Approval / PDUFA |
|---|---|---|---|---|---|---|
| Silicone gel Kelo-cort™; TARGET | Silicone gel Kelo-cort™; | CHA University | phase 3 | Topical corticosteroid with silicone gel base |
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Patent timeline (forward window)
Sponsor landscape (Topical corticosteroid with silicone gel base class)
- CHA University · 1 drug in this class
Subscribe to ongoing alerts
Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:
- Silicone gel Kelo-cort™; CI watch — RSS
- Silicone gel Kelo-cort™; CI watch — Atom
- Silicone gel Kelo-cort™; CI watch — JSON
- Silicone gel Kelo-cort™; alone — RSS
- Whole Topical corticosteroid with silicone gel base class — RSS
Cite this brief
Drug Landscape (2026). Silicone gel Kelo-cort™; — Competitive Intelligence Brief. https://druglandscape.com/ci/silicone-gel-kelo-cort. Accessed 2026-05-16.
Build your own brief
Pick any drug + add comparators:
https://druglandscape.com/ci/{slug}— auto-detected competitorshttps://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3— explicit comparators- Brand names auto-resolve:
/ci/keytruda→ 301 →/ci/pembrolizumab